icad competitors

icad Competitors include Cellectar Biosciences, Ventana Medical Systems, Veracyte and Infervision.
Add company...
icad
iCAD delivers innovative cancer detection solutions that enable clinicians to find cancers earlier and faster while enhancing patient care.
Cellectar Biosciences
Cellectar Biosciences is a clinical stage biopharmaceutical company that engages in the development of targeted phospholipid drug conjugates for the treatment and imaging of cancer.
Ventana Medical Systems
Ventana Medical Systems, Inc., is a world leader and innovator of tissue-based diagnostic solutions for patients worldwide.
Veracyte
Veracyte develops molecular diagnostic tests for thyroid and non-small cell lung cancer.
Infervision
Infervision is an AI high-tech company that uses deep learning technology and computer vision to help diagnose cancers.
Founding Date
Founding Date
N/A
Founding Date
1996
Founding Date
1985
Founding Date
2008
Founding Date
2015
Type
Type
Public
Type
Public
Type
Subsidiary
Type
Public
Type
Private
Tags
Locations
Locations
Nashua, US HQ
San Jose, US
Locations
Madison, US HQ
Locations
Oro Valley, US HQ
Locations
South San Francisco, US HQ
Austin, US
Locations
Beijing, CN HQ
Employees
Employees
116
Employees
15
Employees
N/A
Employees
216
Employees
353% increase
Valuation ($)
Valuation ($)
55 m
Valuation ($)
10.2 m
Valuation ($)
N/A
Valuation ($)
367.1 m
Valuation ($)
N/A
Facebook likes
Facebook likes
266
Facebook likes
97
Facebook likes
131
Facebook likes
N/A
Facebook likes
N/A
Twitter followers
Twitter followers
368
Twitter followers
295
Twitter followers
6.2 k
Twitter followers
502
Twitter followers
N/A

Financial

Revenue (est.)
Revenue (est.)
$26.3m (FY, 2016)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$72m (FY, 2017)
Revenue (est.)
N/A
Cost of goods
Cost of goods
$7.8m (FY, 2016)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$28.2m (FY, 2017)
Cost of goods
N/A
Gross profit
Gross profit
$18.5m (FY, 2016)
Gross profit
N/A
Gross profit
N/A
Gross profit
$43.8m (FY, 2017)
Gross profit
N/A
Net income
Net income
($10.1m) (FY, 2016)
Net income
($13.6m) (FY, 2017)
Net income
N/A
Net income
($31m) (FY, 2017)
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 15m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 116.3m
Total funding raised
$ 92.3m
For sources of this data, please see the company profileDownload Excel

View company profiles

Cellectar Biosciences
HQ
Madison, US
Employees
15

Cellectar Biosciences is a clinical stage biopharmaceutical company that engages in the development of targeted phospholipid drug conjugates for the treatment and imaging of cancer.

View company
Ventana Medical Systems
HQ
Oro Valley, US

Ventana Medical Systems, Inc., is a world leader and innovator of tissue-based diagnostic solutions for patients worldwide.

View company
Veracyte
HQ
South San Francisco, US
Employees
216

Veracyte develops molecular diagnostic tests for thyroid and non-small cell lung cancer.

View company
Infervision
HQ
Beijing, CN
Employees
35↑ 3% increase

Infervision is an AI high-tech company that uses deep learning technology and computer vision to help diagnose cancers.

View company